Skip to main content
. 2014 Jun 27;39(2):243–252. doi: 10.5114/ceji.2014.43730

Fig. 1.

Fig. 1

A) Prevalence of NS in patients with diffuse proliferative renal lesions (class IV) and membranous lesions (class V) versus non-diffuse proliferative lesions (class I + II + III) (p = 0.0005, p = 0.0023, respectively); B) Prevalence of CHOL ≥ 5.7 in patients with diffuse proliferative renal lesions (class IV) versus non-diffuse proliferative lesions (class I + II + III) and membranous lesions (class V) (p = 0.0085, p = 0.3035, respectively). C) Prevalence of ALB ≤ 20 in patients with membranous lesions (class V) versus non-diffuse proliferative lesions (class I + II + III) and diffuse proliferative renal lesions (class IV) (p = 0.0003, P = 0.0348, respectively)